There are 3 different types of mid-urethral sling, retropubic, transobturator and single incision performed for women with stress urinary incontinence. Prior studies comparing these three surgeries merely focused on the successful rate or efficacy.
The purpose of this study is to develop overactive bladder (OAB) phenotypes that can be used to develop diagnostic and treatment pathways and offer clues to the underlying etiologies of patients with OAB.
The aim of this systematic review of the literature was to pool all the existing data regarding pregnancy and delivery in women with neurogenic bladder or bladder exstrophy who had undergone previous lower urinary tract reconstruction (LUTR).
Spinal cord injury (SCI) is one of the most disabling and destructive neurological diseases. Neurogenic bladder dysfunction (NBD) is one of the serious complications after SCI, 80% of patients after SCI will have neurogenic bladder symptoms.
Low-intensity shockwave therapy (LiST) has emerged as an effective treatment for pain in patients with chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), and it has been postulated that LiST may also be effective in patients with lower urinary tract symptoms (LUTS).
Christopher Wallis: Hello, and thank you for joining us for this UroToday Journal Club. Today, we are discussing a recent publication entitled, Overall Survival of Men with Metachronous Metastatic Hormone-sensitive Prostate Cancer Treated with Enzalutamide and Androgen Deprivation Therapy. I’m Chris Wallis, a Fellow in Urologic Oncology at Vanderbilt. With me today is Zach Klaassen, […]
Artificial Intelligence algorithms may automatically quantify radiologic characteristics associated with disease response to medical treatments. We investigated a 3-dimensional deep radiomics pipeline to predict disease control to immunotherapy in 42 consecutive patients with metastatic urothelial cancer. The predictive accuracy of the pipeline was 82.5% and increased to 92.5% with the addition of the imaging of […]
(UroToday.com) PSMA-targeted PET/CT is superior to conventional imaging modalities to localize biochemically recurrent prostate cancer after local therapy, particularly in patients with low PSA (< 2 ng/mL) values. However, few studies have reported PSMA-targeted PET/CT accuracy compared to a pre-specified rigorous standard of truth including histopathology, correlative imaging, or treatment response in this population. The […]
Most testicular cancers at diagnosis are of the localized type, hardly presenting as extensive masses that spread to the scrotum. To the best of our knowledge, no case of large diffuse seminoma spreading into the retroperitoneum through the inguinal canal has previously been described.
Deleterious alterations in genes that are directly or indirectly associated with DNA damage repair (DDR) are enriched in lethal aggressive prostate cancer (PC). About 25–30% of patients with metastatic castration-resistant prostate cancer (mCRPC) harbor loss-of-function alterations in DDR genes and respond to current androgen receptor (AR) inhibitors.1 Recently, PARP inhibitors (PARPi) have shown promise in […]
